Home › Funds › Squadron Capital Management LLC › ZNTL
Squadron Capital Management LLC position in ZNTL
ZENTALIS PHARMACEUTICALS INC · Health Care
Squadron Capital Management LLC reported holding 426,000 shares of ZNTL (ZENTALIS PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$2.1M, representing 0.81% of its reported portfolio and ranking #28 among its reported holdings. Squadron Capital Management LLC has disclosed ZNTL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Squadron Capital Management LLC's ZNTL position evolved
Squadron Capital Management LLC first disclosed a stake in ZNTL in Q1 2026 at 400,000 shares (US$936K). The position peaked in Q2 2026 at 426,000 shares, worth US$2.1M. Across 2 filings, Squadron Capital Management LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 426,000 shares valued at US$2.1M — an increase of 26,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 400.00K | $936.00K | New |
| Q2 2026 | 426.00K | $2.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZNTL and 13F data
ZNTL (ZENTALIS PHARMACEUTICALS INC) is a Health Care company. 29 other funds we track also report a position in ZNTL — the largest reported positions include 5AM Venture Management, LLC (US$19.1M), Opaleye Management Inc. (US$6.9M), Decheng Capital LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZNTL
- 5AM Venture Management, LLC 3.95M sh · $19.15M · Q2 2026
- Opaleye Management Inc. 1.41M sh · $6.85M · Q2 2026
- Decheng Capital LLC 1.32M sh · $6.42M · Q2 2026
- Ishara Investments LP 1.02M sh · $4.97M · Q2 2026
- PFIZER INC 953.83K sh · $3.85M · Q2 2026
More on Squadron Capital Management LLC
FAQ
How long has Squadron Capital Management LLC held ZNTL?
Squadron Capital Management LLC has disclosed ZNTL holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is Squadron Capital Management LLC's current position in ZNTL?
As of Q2 2026, Squadron Capital Management LLC holds 426.00K shares of ZNTL (ZENTALIS PHARMACEUTICALS INC), valued at $2.07M, representing 0.81% of its reported portfolio and ranking #28.
Has Squadron Capital Management LLC been buying or selling ZNTL?
In the latest 13F filing (Q2 2026), Squadron Capital Management LLC increased its position in ZNTL. The position peaked in Q2 2026 at 426.00K shares.
Which other funds hold ZNTL?
Other major institutional holders of ZNTL include 5AM Venture Management, LLC, Opaleye Management Inc., Decheng Capital LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.